Murgai Meera, Ju Wei, Eason Matthew, Kline Jessica, Beury Daniel W, Kaczanowska Sabina, Miettinen Markku M, Kruhlak Michael, Lei Haiyan, Shern Jack F, Cherepanova Olga A, Owens Gary K, Kaplan Rosandra N
Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Nat Med. 2017 Oct;23(10):1176-1190. doi: 10.1038/nm.4400. Epub 2017 Sep 18.
A deeper understanding of the metastatic process is required for the development of new therapies that improve patient survival. Metastatic tumor cell growth and survival in distant organs is facilitated by the formation of a pre-metastatic niche that is composed of hematopoietic cells, stromal cells and extracellular matrix (ECM). Perivascular cells, including vascular smooth muscle cells (vSMCs) and pericytes, are involved in new vessel formation and in promoting stem cell maintenance and proliferation. Given the well-described plasticity of perivascular cells, we hypothesized that perivascular cells similarly regulate tumor cell fate at metastatic sites. We used perivascular-cell-specific and pericyte-specific lineage-tracing models to trace the fate of perivascular cells in the pre-metastatic and metastatic microenvironments. We show that perivascular cells lose the expression of traditional vSMC and pericyte markers in response to tumor-secreted factors and exhibit increased proliferation, migration and ECM synthesis. Increased expression of the pluripotency gene Klf4 in these phenotypically switched perivascular cells promoted a less differentiated state, characterized by enhanced ECM production, that established a pro-metastatic fibronectin-rich environment. Genetic inactivation of Klf4 in perivascular cells decreased formation of a pre-metastatic niche and metastasis. Our data revealed a previously unidentified role for perivascular cells in pre-metastatic niche formation and uncovered novel strategies for limiting metastasis.
为了开发能够提高患者生存率的新疗法,需要对转移过程有更深入的了解。由造血细胞、基质细胞和细胞外基质(ECM)组成的前转移小生境促进了远处器官中转移性肿瘤细胞的生长和存活。包括血管平滑肌细胞(vSMC)和周细胞在内的血管周围细胞参与新血管形成,并促进干细胞维持和增殖。鉴于血管周围细胞具有可塑性,我们推测血管周围细胞同样会在转移部位调节肿瘤细胞的命运。我们使用血管周围细胞特异性和周细胞特异性谱系追踪模型来追踪前转移和转移微环境中血管周围细胞的命运。我们发现,血管周围细胞会响应肿瘤分泌因子而失去传统vSMC和周细胞标志物的表达,并表现出增殖、迁移和ECM合成增加。这些表型转换的血管周围细胞中多能性基因Klf4表达增加,促进了一种分化程度较低的状态,其特征是ECM产生增强,从而建立了一个富含促转移纤连蛋白的环境。血管周围细胞中Klf4的基因失活减少了前转移小生境的形成和转移。我们的数据揭示了血管周围细胞在前转移小生境形成中以前未被识别的作用,并发现了限制转移的新策略。